Showing 1 - 5 results of 5 for search 'Alessandra di Pietro', query time: 0.05s Refine Results
  1. 1
    Irony, Names and Linguistic Resistance: NoViolet Bulawayo’s We Need New Names as a World-Making Narrative

    Irony, Names and Linguistic Resistance: NoViolet Bulawayo’s We Need New Names as a World-Making Narrative by Alessandra Di Pietro

    Published 2022-09-01
    Get full text
    Article
  2. 2
    The linkages between climate change and foot & mouth disease: A One health perspective from nomadic herders in Mongolia

    The linkages between climate change and foot & mouth disease: A One health perspective from nomadic herders in Mongolia by Alessandra DiPietro, Erdene Tserenochir, Erica Garroutte, Rentsen Oyunbat, Iyabo Obasanjo

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma

    Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma by Joanna C. Masters, Akash Khandelwal, Alessandra diPietro, Haiqing Dai, Satjit Brar

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Clinical Evaluation of M30 and M65 ELISA Cell Death Assays as Circulating Biomarkers in a Drug-Sensitive Tumor, Testicular Cancer

    Clinical Evaluation of M30 and M65 ELISA Cell Death Assays as Circulating Biomarkers in a Drug-Sensitive Tumor, Testicular Cancer by Esther C. de Haas, Alessandra di Pietro, Kathryn L. Simpson, Coby Meijer, Albert J.H. Suurmeijer, Lee J. Lancashire, J. Cummings, Steven de Jong, Elisabeth G.E. de Vries, Caroline Dive, Jourik A. Gietema

    Published 2008-10-01
    Get full text
    Article
  5. 5
    Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial

    Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses... by Brian Rini, Mariangela Mariani, Alessandra di Pietro, Paul Nathan, Christian Kollmannsberger, Marc-Oliver Grimm, Martin H Voss, Bradley A McGregor, Mehmet A Bilen, Yoshihiko Tomita, Bo Huang, Robert Amezquita, Matthew Tucker, Yu-Wei Chen

    Published 2024-07-01
    Get full text
    Article

Search Tools: